COMMUNIQUÉS West-GlobeNewswire

Hemostemix Receives Health Canada Clearance to Continue with Critical Limb Ischemia Clinical Trials
20/12/2017
CALGARY, Alberta, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Hemostemix Inc . (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) announced today that they have received a No Objection Letter from Health Canada for its current [...]
K2M Introduces World’s First 3D-Printed Expandable Corpectomy Cage with Cervical Spine Indications Following CE Mark of CAPRI® Cervical 3D Expandable Featuring Lamellar 3D Titanium Technology™
20/12/2017
LEESBURG, Va., Dec. 20, 2017 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Loxo Oncology Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancers
20/12/2017
STAMFORD, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers [...]
Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2017
20/12/2017
OTTAWA, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V: VIV ) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]
Achillion Initiates Phase I First-In Study of ACH-5228, a Next-Generation Oral Small Molecule Inhibitor of Complement Factor D
20/12/2017
NEW HAVEN, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ), a pharmaceutical company focused on advancing small molecule inhibitors of factor D in the complement alternative [...]
Mesoblast’s Phase 3 Trial in Children With Acute Graft Versus Host Disease Completes Enrollment
20/12/2017
NEW YORK and MELBOURNE, Australia, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO ) (ASX:MSB) today announced that the Phase 3 trial of its proprietary allogeneic mesenchymal stem cell (MSC) product [...]
Changes to the Executive Leadership Team
20/12/2017
Novozymes announces the appointment of Ms. Prisca Havranek-Kosicek as new Chief Financial Officer effective February 1, 2018. Ms. Havranek-Kosicek has up until November 2017 served as CFO and member of the Executive [...]
Adventist Health Promotes Joe Reppert as Chief Financial Officer
20/12/2017
ROSEVILLE, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Adventist Health —a non-profit integrated health system serving more than 75 communities on the West Coast and in Hawaii—is proud to announce the recent promotion of [...]
ALK – Financial calendar for the 2018 financial year
20/12/2017
Copenhagen, 2017-12-20 11:06 CET (GLOBE NEWSWIRE) -- 2018 financial calendar for ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): Silent period 9 January 2018 Annual report 2017 6 February 2018 Annual General Meeting to be [...]
NeuroSearch – financial calendar for 2018
20/12/2017
Announcement no. 9-17 Page 1 of 1 Announcement 20 December 2017 NeuroSearch A/S (NEUR) hereby announces the company’s financial calendar for 2018. 9 February 2018 Annual Report 2017 25 April 2018 Annual General Meeting [...]
TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell (eASC) platform
20/12/2017
PRESS RELEASE TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell (eASC) platform Leuven (BELGIUM) - December 20, 2017, 7:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG) ("TiGenix" or " [...]
TiGenix confirme l'orientation stratégique du Cx601 et de la plateforme de cellules souches dérivées de tissus adipeux (eASC)
20/12/2017
COMMUNIQUÉ DE PRESSE TiGenix confirme l'orientation stratégique du Cx601 et de la plateforme de cellules souches dérivées de tissus adipeux (eASC) Louvain (BELGIQUE) - 20 décembre 2017, 07h. CET - TiGenix NV (Euronext [...]
MPX Bioceutical Corporation Provides Update on Private Placement
20/12/2017
TORONTO, Dec. 19, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corp. (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) is pleased to provide this corporate update concerning its previously announced brokered private [...]
Skyline Medical Acquiring up to 25% Equity Stake in Helomics Corporation, a Precision Diagnostics Company
19/12/2017
MINNEAPOLIS, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
19/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer
19/12/2017
DOYLESTOWN, Pa., Dec. 19, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ), a diversified natural health medical science company (“ProPhase”), announced today the preliminary results [...]
Galectin Therapeutics Announces $10 Million Credit Line from Richard E. Uihlein Sufficient to Cover Expected Expenditures Into 2019
19/12/2017
NORCROSS, Ga., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced it entered into a $10 million unsecured [...]
Five Prime Therapeutics and Zai Lab Announce Exclusive License Agreement for FPA144 Anti-FGFR2b Antibody in Greater China and Global Strategic Development Collaboration
19/12/2017
SOUTH SAN FRANCISCO, Calif. and SHANGHAI, China, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc . (NASDAQ: FPRX ), a biotechnology company discovering and developing innovative immuno-oncology protein [...]
SDi Announces Planned Release of 2018 Global Assessment Report
19/12/2017
LOS ANGELES, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Strategic Directions International (SDi), a division of BioInformatics LLC, announced today the 2018 Global Assessment Report: The Laboratory Analytical & Life [...]

Pages